Biosimilars Market Amplifies from USD 3.35 Billion in 2016 to USD 16.97 Billion by 2023 Registering a CAGR of 26%; Asserts MRFR
Global biosimilars market research report, by product (recombinant glycosylated proteins, recombinant non-glycosylated proteins and other), by application (Immune diseases, oncology, blood related disorders, other) manufacturing (contract, and in-house) - Forecast Till 2023
View full press release